4//SEC Filing
Klobuchar Michael A 4
Accession 0001127602-23-014204
CIK 0000310158other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 3:00 PM ET
Size
11.5 KB
Accession
0001127602-23-014204
Insider Transaction Report
Form 4
Klobuchar Michael A
EVP - Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-01$115.47/sh+866$99,997→ 18,901.461 total - Tax Payment
Common Stock
2023-05-01$115.47/sh−427$49,306→ 18,590.999 total - Exercise/Conversion
Restricted Stock Unit
2023-05-01−866→ 0 totalFrom: 2021-05-01Exp: 2023-05-01→ Common Stock (866 underlying)
Holdings
- 6.292(indirect: By Children)
Common Stock
- 6.292(indirect: By Children)
Common Stock
- 844.856(indirect: By 401(k))
Common Stock - 401(k) Plan
- 680.042(indirect: By Spouse)
Common Stock - 401(k) Plan
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 10, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001871957
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 3:00 PM ET
- Size
- 11.5 KB